Wave Life Sciences Ltd. (WVE)
11.47
0.34 (3.05%)
At close: Jan 15, 2025, 11:51 AM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| PE Ratio | -9.32 | -3.41 | -1.33 | -2.06 | -1.51 | -8.3 | -9.12 | -10.76 | -8.72 | -64.05 | -100.94 |
| PS Ratio | 4.73 | 151.27 | 3.97 | 15.38 | 16.99 | 84.50 | 251.25 | 401.51 | 1.10K | n/a | n/a |
| PB Ratio | 11.28 | -12.24 | 5.01 | 3.73 | 4.26 | 16.60 | 6.66 | 4.42 | 1.09 | 165.24 | -43.15 |
| P/FCF Ratio | -26.08 | -4.27 | -1.82 | -2.63 | -1.41 | -37.13 | -9.07 | -15.93 | -11.64 | -66.77 | -93.09 |
| P/OCF Ratio | -27.57 | -4.32 | -1.83 | -2.66 | -1.44 | -53.27 | -11.12 | -18.71 | -13.37 | -75.67 | -94.32 |
| OCF/S Ratio | -0.17 | -35.02 | -2.17 | -5.78 | -11.78 | -1.59 | -22.59 | -21.46 | -82.41 | n/a | n/a |
| Debt / Equity Ratio | 0.68 | -0.83 | 0.92 | 0.35 | 0.51 | 0.14 | 0.02 | 0.00 | 0.00 | n/a | -1.24 |
| Quick Ratio | 1.26 | 1.38 | 2.53 | 1.81 | 1.49 | 1.56 | 7.67 | 12.50 | 42.27 | 1.50 | 0.08 |
| Current Ratio | 1.26 | 1.38 | 2.53 | 1.90 | 1.57 | 1.56 | 7.67 | 12.50 | 42.27 | 1.69 | 0.08 |
| Asset Turnover | 0.41 | 0.02 | 0.20 | 0.07 | 0.06 | 0.05 | 0.02 | 0.01 | 0.00 | n/a | n/a |
| Interest Coverage | n/a | n/a | n/a | -9.59K | n/a | -7.25K | -17.10K | -164.18 | -224.4 | -449.5 | n/a |
| Return on Equity (ROE) | -1.21 | 3.59 | -3.76 | -1.81 | -2.82 | -2 | -0.73 | -0.41 | -0.13 | -2.58 | 0.43 |
| Return on Assets (ROA) | -0.21 | -1.11 | -0.59 | -0.54 | -0.63 | -0.5 | -0.56 | -0.34 | -0.12 | -1.78 | -1.43 |
| Return on Capital (ROIC) | -0.77 | -2.17 | -0.89 | -0.97 | -1.25 | -0.96 | -0.63 | -0.36 | -0.12 | -2.62 | 0.46 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 91.88% | -177.17% | -197.52% | -518.44% | -997.61% | -832.62% | -2.04K% | 73.54% | -5.86K% | n/a | n/a |
| Net Profit Margin | -50.76% | -4.43K% | -298.42% | -746.68% | -1.12K% | -1.02K% | -2.75K% | -3.73K% | -12.63K% | n/a | n/a |
| Pretax Profit Margin | -51.36% | -4.42K% | -298.92% | -750.86% | -1.21K% | -1.02K% | -2.74K% | -3.69K% | -12.60K% | n/a | n/a |
| Operating Profit Margin | -60.01% | -4.46K% | -310.07% | -763.94% | -1.30K% | -1.11K% | -2.77K% | -3.73K% | -12.70K% | n/a | n/a |
| FCF Margin | -18.13% | -3.54K% | -218.61% | -584.35% | -1.20K% | -227.56% | -2.77K% | -2.52K% | -9.46K% | n/a | n/a |
| EBITDA Margin | -51.89% | -4.18K% | -286.06% | -714.22% | -1.26K% | -1.07K% | -2.71K% | -3.70K% | -12.21K% | n/a | n/a |